Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06826339 · ClinicalTrials.gov registry record · Phase 4
Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot and Venous Leg Ulcers.
A Phase 4 study of Diabetic Foot Ulcer and Venous Leg Ulcer, sponsored by Tiger Biosciences.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 340
- Enrollment target
- 1
- Study location
NCT06826339: Recruiting Phase 4 study of Diabetic Foot Ulcer and Venous Leg Ulcer, sponsored by Tiger Biosciences.
NCT06826339 is a Phase 4 study of Diabetic Foot Ulcer and Venous Leg Ulcer that is actively recruiting participants, run by Tiger Biosciences. The registered enrollment target is 340 participants, above the 250-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (36% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06826339, a Phase 4 study of Diabetic Foot Ulcer and Venous Leg Ulcer, is actively recruiting participants, sponsored by Tiger Biosciences.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 340 participants
- Enrollment target
- 1
- Study location
Study Summary
Title A Multicenter, Prospective, Randomized Controlled Modified Multi-Platform (Matriarch) Trial Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care versus Standard of Care alone in the Management of Nonhealing Diabetic Foot and Venous Leg Ulcers.
Primary Outcome
To determine the between-arm difference in the proportion of subjects achieving complete closure of nonhealing diabetic foot ulcers and venous leg ulcers with multiple CAMPs plus SOC versus SOC alone over 12 weeks using a modified dual platform (Matriarch) trial design. The platform design permits the inclusion of additional products by amending the protocol.
Conditions Studied
Interventions
- OTHER Standard of Care
- OTHER ACApatch™
- OTHER caregraFT™
Study Locations (1)
Pennsylvania
- Serena Group - Monroeville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 340 participants |
| Start Date | 2024-12-06 |
| Est. Completion | 2027-12 |
| Phase | Phase 4 |
What NCT06826339 shows while recruiting
NCT06826339 is an interventional study that assigns participants to a tested intervention. The registered 340 participants enrollment target is mid-sized for trials with a published cap, above the 250-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (36% higher).
The record links to 9 conditions, with Diabetic Foot Ulcer appearing as the primary indexed condition, and to 3 interventions - of which Standard of Care is the first listed.
NCT06826339 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06826339 about?
NCT06826339 is a clinical study titled "Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot and Venous Leg Ulcers.". Title A Multicenter, Prospective, Randomized Controlled Modified Multi-Platform (Matriarch) Trial Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care versus Standard of Care alone in the Management of Nonhealing Diabetic Foot and Venous Leg Ulcers.
What is the current status of trial NCT06826339?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 340 participants. The study started on 2024-12-06. Estimated completion is 2027-12.
What conditions does trial NCT06826339 study?
This clinical trial studies the following conditions: Diabetic Foot Ulcer, Venous Leg Ulcer, Diabetic Foot, Ulcer, Ulcer Foot.
What interventions are being tested in trial NCT06826339?
The interventions under investigation include: Standard of Care (OTHER), ACApatch™ (OTHER), caregraFT™ (OTHER).
Who is sponsoring clinical trial NCT06826339?
This trial is sponsored by Tiger Biosciences, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06826339 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Foot Ulcer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06826339's enrollment target sits among peer trials
340 9th of 67 higher than 59 of 67 other Diabetic Foot Ulcer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetic Foot Ulcer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Randomized Evaluation of Nonhealing Diabetic Foot Ulcers With Exclusive Wound Therapy
RECRUITING · Phase 4
-
Nonhealing Diabetic Foot Ulcers Treated With Standard of Care (SOC) Alone or Standard of Care and Amnion-Intermediate-Chorion (AIC)
RECRUITING · Phase 4
-
A Multicenter, Prospective, Controlled Clinical Trial Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers
RECRUITING · Phase 4
-
Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers
RECRUITING · Phase 4
-
A Multicenter, Prospective, Controlled Modified Multi-Platform Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers.
RECRUITING · Phase 4
-
Study Evaluating Several CAMPs in Nonhealing Diabetic Foot and Venous Leg Ulcers
ACTIVE NOT RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04176172 · 340 participants · Phase 3
Optimizing Tobacco Use Treatment for PLWHA
- NCT04545424 · 340 participants · Phase 2
Trial of Therapeutic Hypothermia in Patients With ARDS
- NCT04806958 · 340 participants · NA
The PulsePoint Study
- NCT05323409 · 340 participants · NA
Improving Comprehensive Care of Cancer Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI